From: A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma
Ensembl id | Gene symbol | Genomic location | Coefficient | Hazard ratio | 95% CI | P Value |
---|---|---|---|---|---|---|
ENSG00000260684 | RP11-1072A3.3.1 | chr16: 30,995,950–30,999,591 | 2.695 | 14.805 | 3.546–61.82 | <0.001 |
ENSG00000229589 | ACVR2B-AS1 | chr 3: 38,451,027–38,454,820 | 1.038 | 2.823 | 1.522–5.237 | 0.001 |
ENSG00000224037 | RP4-781 K5.7.1 | chr1: 234,845,004–234,855,723 | 2.331 | 10.289 | 2.419–43.76 | 0.002 |
ENSG00000235499 | AC073046.25 | chr 2: 73,985,132–73,986,343 | 0.798 | 2.220 | 1.337–3.687 | 0.002 |
ENSG00000224905 | AP001347.6 | chr 21: 14,027,421–14,144,468 | 0.722 | 2.058 | 1.297–3.264 | 0.002 |
ENSG00000260992 | DOCK9-AS2 | chr 13: 99,087,819–99,088,625 | 0.306 | 1.358 | 1.11–1.661 | 0.003 |
ENSG00000248008 | NRAV | chr 12: 120,490,328–120,495,940 | −0.236 | 0.790 | 0.67–0.9313 | 0.005 |
ENSG00000234945 | GTF3C2-AS1 | chr 2: 27,335,535–27,342,599 | 4.013 | 55.321 | 3.258–939.3 | 0.005 |
ENSG00000182648 | LINC01006 | chr 7: 156,472,196–156,640,654 | 0.665 | 1.945 | 1.208–3.133 | 0.006 |
ENSG00000253636 | RP11-531A24.5 | chr 8: 73,052,178–73,063,061 | 0.410 | 1.507 | 1.107–2.052 | 0.009 |
ENSG00000233760 | AC004947.2 | chr 7: 26,551,822–26,557,200 | 0.172 | 1.187 | 1.042–1.353 | 0.010 |